Multiple myeloma (MM) has seen significant treatment advancements, including immune modulators, proteasome inhibitors, and chimeric antigen receptor T cell therapies, resulting in a tripling of median overall survival.

Read More> https://multiplemyeloma.pocn.com/patient-management/integrative-approaches-in-multiple-myeloma-managing-symptoms-and-improving-quality-of-life/